University of Colorado football coach Deion Sanders says he feels like his younger self again after undergoing surgery to ...
The Colorado head coach documented his journey on social media, including a lengthy hospital stay that had many skeptical he ...
One year after the first human bladder transplant, the patient is thriving and the UCLA Health surgeon who performed the ...
Inlexzo is a new treatment for a type of bladder cancer in adults that hasn’t spread to the muscles and doesn’t respond to Bacillus Calmette-Guérin (BCG) therapy. It’s approved for treating non-muscle ...
Bladder cancer is the fourth most commonly diagnosed cancer in men in the United States and the 10th leading cause of cancer deaths. Many treatments can be used for bladder cancer, and the kind of ...
Researchers at Weill Cornell Medicine, Cedars-Sinai Medical Center and Roswell Park Comprehensive Cancer Center have ...
Deion Sanders is embracing a new normal following his bladder removal surgery last month. The former NFL star was forced to bring a portable toilet to Folsom Field while joining the team he coaches, ...
Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for muscle-invasive bladder cancer, but it is not a good predictor of local recurrence ...
Researchers at the Icahn School of Medicine at Mount Sinai have reported promising findings that may help redefine treatment for patients with muscle-invasive bladder cancer, a potentially aggressive ...
17don MSN
39% of women with bladder cancer were first told they had a UTI – these are the 9 symptoms to know
A consultant urologist explains why bladder cancer is often mistaken for a urinary tract infection in women – and the warning signs that should never be ignored ...
Squamous cell carcinoma of the bladder is rare, accounting for 2% to 5% of bladder cancers in the U.S., and is linked to chronic bladder irritation. Diagnosis involves cystoscopy, biopsy, and imaging ...
Fox Chase Cancer Center researchers reported positive results from the trial, known as RETAIN-2, demonstrating that a response-adapted bladder-preservation approach involving neoadjuvant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results